A collagen supplement containing collagen types I, II, V, and X improved symptoms of joint pain in a new study.
A review of existing data suggests that a balanced diet, rather than long-term restriction of carbohydrates or any other single nutrient, maintains a diverse population of intestinal flora and improves metabolic imbalance in patients with RA.
In a review of 68 existing studies, researchers found that weight reduction, in particular, can help to reduce the progression of osteoarthritis symptoms. They also found that lipid-modifying diets may contribute to reduced symptoms, though the evidence for that outcome was more sparse.
NattoPharma is looking to harness its extensive body of research showing vitamin K2’s heart- and bone-health benefits, as well as establishing clinical biomarkers to demonstrate the consequences of vitamin K2 deficiency, with the hope of one day seeing the creation of a Recommended Daily Intake (RDI) value for K2.
Bioiberica introduced its new Articolageno Caps formula, which is scheduled to launch at the end of the year, and showcased new research on its Tendoactive food supplement for tendon health, at May’s Vitafoods Europe show.
Collagen foods and beverages are expanding the ingredient’s fan base.
In the study, Mythocondro reduced subjects’ knee pain and improved knee function over placebo.
New study results support the development of a new bone-health probiotic category for the company, Probi says.
Sabinsa announced that in April, the United States District Court in New Jersey awarded the company $850,000 in damages, ruling that Olive Lifesciences infringed on Sabinsa’s patent covering novel methods and formulations for producing tetrahydrocurcuminoids.
AIDP will distribute Kappa Bioscience’s patented vitamin K2 MK-7 Ingredient, K2Vital, to the U.S. dietary supplements market.